Bardia Hajikarimloo
Overview
Explore the profile of Bardia Hajikarimloo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tos S, Hajikarimloo B, Mantziaris G, Ishaque M, Ramanathan P, Schlesinger D, et al.
Acta Neurochir (Wien)
. 2025 Mar;
167(1):73.
PMID: 40085175
Background: Leukoencephalopathy is the most prevalent and delayed adverse radiation effect (ARE) after intracranial radiotherapy (RT). Patients with leukoencephalopathy experience some levels of cognitive and neurological dysfunction. This investigation assessed...
2.
Ansari A, Tavanaei R, Alikhani A, Hajikarimloo B, Zoghi S, Alnemari A, et al.
Neurosurg Rev
. 2025 Mar;
48(1):285.
PMID: 40050528
Hemifacial spasm (HFS) is a distressing condition caused by facial nerve compression and characterized by involuntary facial muscle twitching, adversely impacting quality of life. Microvascular decompression (MVD) is effective but...
3.
Habibi M, Ahmadvand M, Delbari P, Mirjani M, Zare A, Mehdizadeh B, et al.
J Clin Neurosci
. 2025 Mar;
135:111138.
PMID: 40022869
Background: Gliomas, particularly glioblastoma (GBM), remain challenging to treat and have a poor prognosis. Tyrosine kinase inhibitors (TKIs) targeting EGFR have shown promise, but their efficacy in gliomas is not...
4.
Mortezaei A, Hajikarimloo B, Eraghi M, Sheikholeslami S, Azzam A, Roach C, et al.
Neurosurg Focus
. 2025 Mar;
58(3):E10.
PMID: 40022746
Objective: Understanding racial and socioeconomic disparities in mechanical thrombectomy (MT) for acute ischemic stroke (AIS) is crucial to addressing these critical healthcare challenges. The authors aimed to evaluate racial and...
5.
Hajikarimloo B, Mohammadzadeh I, Tos S, Hashemi R, Habibi M, Hasanzade A, et al.
Neuroradiol J
. 2025 Feb;
:19714009251324324.
PMID: 40016880
Background: The Silk Vista Baby (SVB) flow diverter (FD) is a stent designed for small vessels ranging from 1.5 to 3.5 mm. It is the only FD deliverable through a...
6.
Tos S, Osama M, Mantziaris G, Hajikarimloo B, Adeeb N, Kandregula S, et al.
Neurosurg Rev
. 2025 Feb;
48(1):276.
PMID: 40016553
Cerebral arteriovenous malformations (AVMs) are congenital vascular anomalies that can lead to severe complications, including hemorrhage and neurological deficits. This study compares the outcomes of microsurgical resection and stereotactic radiosurgery...
7.
Delbari P, Ahmadvand M, Mirjani M, Hajikarimloo B, Rad R, Kargar-Soleimanabad S, et al.
Neurosurg Rev
. 2025 Feb;
48(1):253.
PMID: 39969599
Individuals with non-small cell lung cancer (NSCLC) who develop brain metastases face a poor prognosis and limited treatment options. Programmed cell death protein 1 (PD-1) inhibitors, such as pembrolizumab and...
8.
Mohammadzadeh I, Hajikarimloo B, Niroomand B, Eini P, Ghanbarnia R, Habibi M, et al.
Neurosurg Rev
. 2025 Feb;
48(1):240.
PMID: 39954167
High-grade glioma (HGG) is an aggressive brain tumor with poor survival rates. Predicting survival outcomes is critical for personalized treatment planning. In recent years, artificial intelligence (AI), particularly machine learning...
9.
Habibi M, Delbari P, Rashidi F, Hajikarimloo B, Allahdadi A, Rouzrokh S, et al.
Clin Exp Metastasis
. 2025 Feb;
42(2):17.
PMID: 39928191
Combining radiotherapy (RT) with Ipilimumab, a CTLA-4 inhibitor, holds promise in treating metastatic brain melanoma (MBM). Despite promising preclinical evidence, clinical studies evaluating their combined efficacy are limited and varied,...
10.
Habibi M, Rashidi F, Gharedaghi H, Tavani S, Farzalizadeh H, Shahir Eftekhar M, et al.
Neurosurg Rev
. 2025 Feb;
48(1):226.
PMID: 39920453
Glioma is one of the most common CNS malignancies with a high mortality rate. Overexpression of endothelial growth factor receptor (EGFR) has been suspected to play a critical role in...